Atlas Trials

Does Cannabidiol Attenuate the Acute Effects of ∆9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental Study

Clinical trial NCT04605393 · COMPLETED

Trial details

NCT number
NCT04605393
Sponsor
King's College London
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
SchizophreniaCannabis Use
Start date
2021-01-01
Primary completion
2023-07-07
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.